SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000899923-23-000117
Filing Date
2023-12-21
Accepted
2023-12-21 08:30:28
Documents
17
Period of Report
2023-12-15
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K mygn-20231215.htm   iXBRL 8-K 40021
2 EX-99.1 myriadgeneticschieffinan.htm EX-99.1 9924
7 myriadgeneticschieffinan001.jpg GRAPHIC 176839
8 myriadgeneticschieffinan002.jpg GRAPHIC 215403
9 myriadgeneticschieffinan003.jpg GRAPHIC 216494
  Complete submission text file 0000899923-23-000117.txt   1049790

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mygn-20231215.xsd EX-101.SCH 2140
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mygn-20231215_def.xml EX-101.DEF 14426
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mygn-20231215_lab.xml EX-101.LAB 27876
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mygn-20231215_pre.xml EX-101.PRE 15012
11 EXTRACTED XBRL INSTANCE DOCUMENT mygn-20231215_htm.xml XML 2707
Mailing Address 322 NORTH 2200 WEST SALT LAKE CITY UT 84116
Business Address 322 NORTH 2200 WEST SALT LAKE CITY UT 84116 801-584-3600
MYRIAD GENETICS INC (Filer) CIK: 0000899923 (see all company filings)

IRS No.: 870494517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-26642 | Film No.: 231502878
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)